Clinical translation of the GRPR antagonist [99mTc]Tc-maSSS-PEG2-RM26 for targeting prostate tumors

被引：0
|
作者：
Orlova, Anna [1 ]
Abouzayed, Ayman [1 ]
Rinne, Sara [1 ]
Lushnikova, Nadezhda [2 ]
Usynin, Evgeny [2 ]
Doroshenko, A. [2 ]
Borin, Jesper [3 ]
Sorensen, Jens [1 ]
Tolmachev, Vladimir [1 ]
Chernov, Vladimir [2 ]
Rybina, Anastasia [2 ]
机构：
[1] Uppsala Univ, Uppsala, Sweden
[2] Russian Acad Sci, Tomsk Natl Res Med Ctr, Moscow, Russia
[3] KTH Royal Inst Technol, Stockholm, Sweden
来源：
NUCLEAR MEDICINE AND BIOLOGY | 2022年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P-54
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 49 条
  • [1] Clinical translation of the GRPR antagonist [99mTc]Tc-maSSS-PEG 2-RM26 for targeting prostate tumors
    Abouzayed, A.
    Rinne, S. S.
    Lushnikova, N.
    Rybina, A.
    Usynin, E.
    Sorensen, J.
    Tolmachev, V.
    Chernov, V.
    Orlova, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S16 - S17
  • [2] Phase I evaluation of [99mTc]Tc-maSSS-PEG2-RM26 for imaging of GRPR expression
    Orlova, A.
    Rybina, A.
    Lushnikova, N.
    Doroshenko, A.
    Usynin, E.
    Sorensen, J.
    Abouzayed, A.
    Rinne, S. S.
    Tolmachev, V.
    Chernov, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S217 - S218
  • [3] The GRPR Antagonist [99mTc]Tc-maSSS-PEG2-RM26 towards Phase I Clinical Trial: Kit Preparation, Characterization and Toxicity
    Abouzayed, Ayman
    Borin, Jesper
    Lundmark, Fanny
    Rybina, Anastasiya
    Hober, Sophia
    Zelchan, Roman
    Tolmachev, Vladimir
    Chernov, Vladimir
    Orlova, Anna
    DIAGNOSTICS, 2023, 13 (09)
  • [4] Phase I trial for SPECT imaging of GRPR expression in malignant tumors using [99mTc]Tc-maSSS-PEG2-RM26 prepared using one-pot labeling kit
    Orlova, Anna
    Rybina, Anastasia
    Abouzayed, Ayman
    Rinne, Sara
    Zelchan, Roman
    Medvedeva, Anna
    Bragina, Olga
    Lushnikova, Nadezhda
    Doroshenko, A.
    Usynin, Evgeny
    Tashireva, Liubov
    Vtorushin, Sergei
    Sorensen, Jens
    Chernov, Vladimir
    Tolmachev, Vladimir
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S48 - S49
  • [5] Phase I Trial of [99mTc]Tc-maSSS-PEG2-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors
    Chernov, Vladimir
    Rybina, Anastasiya
    Zelchan, Roman
    Medvedeva, Anna
    Bragina, Olga
    Lushnikova, Nadejda
    Doroshenko, Artem
    Usynin, Evgeniy
    Tashireva, Liubov
    Vtorushin, Sergey
    Abouzayed, Ayman
    Rinne, Sara S.
    Sorensen, Jens
    Tolmachev, Vladimir
    Orlova, Anna
    CANCERS, 2023, 15 (06)
  • [6] Preclinical Evaluation of 99mTc-Labeled GRPR Antagonists maSSS/SES-PEG2-RM26 for Imaging of Prostate Cancer
    Abouzayed, Ayman
    Rinne, Sara S.
    Sabahnoo, Hamideh
    Sorensen, Jens
    Chernov, Vladimir
    Tolmachev, Vladimir
    Orlova, Anna
    PHARMACEUTICS, 2021, 13 (02) : 1 - 14
  • [7] [99mTc]Tc-HYNIC-RM2: A potential SPECT probe targeting GRPR expression in prostate cancers
    Vats, Kusum
    Chakraborty, Avik
    Rakshit, Sutapa
    Damle, Archana
    Sarma, Haladhar Dev
    Satpati, Drishty
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 118
  • [8] Evaluation of mercaptoacetyl-based amino acid containing chelators for labeling of GRPR antagonist PEG2-RM26 with 99mTc
    Sabahnoo, H.
    Abouzayed, A.
    Rinne, S.
    Tolmachev, V.
    Orlova, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S674 - S674
  • [9] Testing the potential therapeutic use of [188Re]Re-maSSS/maSES-PEG2-RM26 as part of a theranostic pair with their [99mTc]Tc-labeled counterparts
    Kanellopoulos, P.
    Abouzayed, Q. Yu A.
    Bezverkhniaia, E.
    Tolmachev, V.
    Orlova, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S336 - S336
  • [10] Evaluation of maSSS/maSES-PEG2-RM26 for their potential therapeutic use after labeling with Re-188. Could their [99mTc]Tc-labeled counterparts be used to estimate dosimetry?
    Kanellopoulos, Panagiotis
    Yu, Quanyi
    Abouzayed, Abouzayed
    Bezverkhniaia, Ekaterina
    Tolmachev, Vladimir
    Orlova, Anna
    EJNMMI RADIOPHARMACY AND CHEMISTRY, 2025, 10 (01)
12345